Literature DB >> 19937650

Potentially amyloidogenic conformational intermediates populate the unfolding landscape of transthyretin: insights from molecular dynamics simulations.

J Rui Rodrigues1, Carlos J V Simões, Cândida G Silva, Rui M M Brito.   

Abstract

Protein aggregation into insoluble fibrillar structures known as amyloid characterizes several neurodegenerative diseases, including Alzheimer's, Huntington's and Creutzfeldt-Jakob. Transthyretin (TTR), a homotetrameric plasma protein, is known to be the causative agent of amyloid pathologies such as FAP (familial amyloid polyneuropathy), FAC (familial amyloid cardiomiopathy) and SSA (senile systemic amyloidosis). It is generally accepted that TTR tetramer dissociation and monomer partial unfolding precedes amyloid fibril formation. To explore the TTR unfolding landscape and to identify potential intermediate conformations with high tendency for amyloid formation, we have performed molecular dynamics unfolding simulations of WT-TTR and L55P-TTR, a highly amyloidogenic TTR variant. Our simulations in explicit water allow the identification of events that clearly discriminate the unfolding behavior of WT and L55P-TTR. Analysis of the simulation trajectories show that (i) the L55P monomers unfold earlier and to a larger extent than the WT; (ii) the single alpha-helix in the TTR monomer completely unfolds in most of the L55P simulations while remain folded in WT simulations; (iii) L55P forms, early in the simulations, aggregation-prone conformations characterized by full displacement of strands C and D from the main beta-sandwich core of the monomer; (iv) L55P shows, late in the simulations, severe loss of the H-bond network and consequent destabilization of the CBEF beta-sheet of the beta-sandwich; (v) WT forms aggregation-compatible conformations only late in the simulations and upon extensive unfolding of the monomer. These results clearly show that, in comparison with WT, L55P-TTR does present a much higher probability of forming transient conformations compatible with aggregation and amyloid formation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19937650      PMCID: PMC2865717          DOI: 10.1002/pro.289

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  56 in total

1.  Analysis methods for comparison of multiple molecular dynamics trajectories: applications to protein unfolding pathways and denatured ensembles.

Authors:  S L Kazmirski; A Li; V Daggett
Journal:  J Mol Biol       Date:  1999-07-02       Impact factor: 5.469

2.  Molecular dynamics simulation of the aggregation of the core-recognition motif of the islet amyloid polypeptide in explicit water.

Authors:  Giorgio Colombo; Isabella Daidone; Ehud Gazit; Andrea Amadei; Alfredo Di Nola
Journal:  Proteins       Date:  2005-05-15

3.  A structural model of an amyloid protofilament of transthyretin.

Authors:  Bruno E Correia; Nuno Loureiro-Ferreira; J Rui Rodrigues; Rui M M Brito
Journal:  Protein Sci       Date:  2005-12-01       Impact factor: 6.725

4.  The V122I cardiomyopathy variant of transthyretin increases the velocity of rate-limiting tetramer dissociation, resulting in accelerated amyloidosis.

Authors:  X Jiang; J N Buxbaum; J W Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

Review 5.  Submillisecond kinetics of protein folding.

Authors:  W A Eaton; V Muñoz; P A Thompson; C K Chan; J Hofrichter
Journal:  Curr Opin Struct Biol       Date:  1997-02       Impact factor: 6.809

6.  Molecular dynamics simulation of protein denaturation: solvation of the hydrophobic cores and secondary structure of barnase.

Authors:  A Caflisch; M Karplus
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

7.  Hydrophilicity of cavities in proteins.

Authors:  L Zhang; J Hermans
Journal:  Proteins       Date:  1996-04

8.  Exposure of cryptic epitopes on transthyretin only in amyloid and in amyloidogenic mutants.

Authors:  G Goldsteins; H Persson; K Andersson; A Olofsson; I Dacklin; A Edvinsson; M J Saraiva; E Lundgren
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

9.  The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid.

Authors:  Z Lai; W Colón; J W Kelly
Journal:  Biochemistry       Date:  1996-05-21       Impact factor: 3.162

View more
  11 in total

1.  Pathogenic Mutations Induce Partial Structural Changes in the Native β-Sheet Structure of Transthyretin and Accelerate Aggregation.

Authors:  Kwang Hun Lim; Anvesh K R Dasari; Renze Ma; Ivan Hung; Zhehong Gan; Jeffery W Kelly; Michael C Fitzgerald
Journal:  Biochemistry       Date:  2017-08-30       Impact factor: 3.162

2.  Localized structural fluctuations promote amyloidogenic conformations in transthyretin.

Authors:  Kwang Hun Lim; H Jane Dyson; Jeffery W Kelly; Peter E Wright
Journal:  J Mol Biol       Date:  2013-01-11       Impact factor: 5.469

3.  Cluster analysis of molecular simulation trajectories for systems where both conformation and orientation of the sampled states are important.

Authors:  Tigran M Abramyan; James A Snyder; Aby A Thyparambil; Steven J Stuart; Robert A Latour
Journal:  J Comput Chem       Date:  2016-06-12       Impact factor: 3.376

4.  Edge Strand Dissociation and Conformational Changes in Transthyretin under Amyloidogenic Conditions.

Authors:  Matthew C Childers; Valerie Daggett
Journal:  Biophys J       Date:  2020-10-20       Impact factor: 4.033

5.  Cooperative stabilization of transthyretin by clusterin and diflunisal.

Authors:  Michael J Greene; Elena S Klimtchuk; David C Seldin; John L Berk; Lawreen H Connors
Journal:  Biochemistry       Date:  2014-12-24       Impact factor: 3.162

6.  A FTIR microspectroscopy study of the structural and biochemical perturbations induced by natively folded and aggregated transthyretin in HL-1 cardiomyocytes.

Authors:  Diletta Ami; Paolo Mereghetti; Manuela Leri; Sofia Giorgetti; Antonino Natalello; Silvia Maria Doglia; Massimo Stefani; Monica Bucciantini
Journal:  Sci Rep       Date:  2018-08-21       Impact factor: 4.379

7.  Molecular dynamics simulation study of AG10 and tafamidis binding to the Val122Ile transthyretin variant.

Authors:  Kevin F Morris; Riley M Geoghegan; Emily E Palmer; Matthew George; Yayin Fang
Journal:  Biochem Biophys Rep       Date:  2020-01-17

8.  Dynamics and Thermodynamics of Transthyretin Association from Molecular Dynamics Simulations.

Authors:  Cedrix J Dongmo Foumthuim; Alessandra Corazza; Rodolfo Berni; Gennaro Esposito; Federico Fogolari
Journal:  Biomed Res Int       Date:  2018-06-05       Impact factor: 3.411

9.  Biophysical characterization and modulation of Transthyretin Ala97Ser.

Authors:  Yo-Tsen Liu; Yueh-Jung Yen; Frans Ricardo; Yu Chang; Pei-Hao Wu; Shing-Jong Huang; Kon-Ping Lin; Tsyr-Yan Yu
Journal:  Ann Clin Transl Neurol       Date:  2019-09-10       Impact factor: 4.511

10.  Exploration of the Misfolding Mechanism of Transthyretin Monomer: Insights from Hybrid-Resolution Simulations and Markov State Model Analysis.

Authors:  Shuangyan Zhou; Jie Cheng; Ting Yang; Mingyue Ma; Wenying Zhang; Shuai Yuan; Glenn V Lo; Yusheng Dou
Journal:  Biomolecules       Date:  2019-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.